AzTrials
AzTrials

Substance UseCCPNCT02147743

Preventing Adolescents From Entering the Juvenile Justice System

A study testing CCP+MDFT and CCP+SAU in people with Substance Use and Delinquency, run by University of Miami at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled study tests an innovative juvenile diversion model that integrates evidence-based family therapy.Immediate and longer term effects of the family intervention will be compared to Services As Usual with 120 adolescents participating in Miami-Dade's Civil Citation Program. Read more about this study

Who is it for?
Ages 12 to 17 yearsHealthy volunteers can take part
Conditions the study is for
Substance Use, Delinquency
What is being tested?
CCP+MDFT and CCP+SAU
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteUnited States
Study dates
May 2009to Jan 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 17 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Youth 12 to 17 years old
  • Parent or guardian willing to participate in assessments/treatment
  • Demonstrate risk for mental health, substance abuse, or anger/adjustment problems on the Juvenile Services Department screening warranting intervention but not requiring residential treatment

Who cannot join

  • Youth under the age of 12 or over the age of 18
  • Parent/guardian not willing to participate in assessments and treatment
  • Youth not demonstrating mental health, substance abuse or anger/adjustment problems
  • Youth requiring residential treatment
  • Youth with severe mental illness or retardation

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Miami Miller School of Medicine

    Miami, Florida, 33136

Other trials in United States

About this study

Official title: Preventing Adolescents From Entering the Juvenile Justice System: Testing An Empirically-Supported, Family-Based Diversion Model

This randomized controlled study tests an innovative juvenile diversion model that integrates evidence-based family therapy.Immediate and longer term effects of the family intervention will be compared to Services As Usual with 120 adolescents participating in Miami-Dade's Civil Citation Program.

Read the detailed description

This study proposes to rigorously test the innovative Civil Citation Program (CCP)with an integrated evidence-based family intervention, Multidimensional Family Therapy[MDFT](Liddle, 2002).

The study sample includes youth referred to the CCP throughout Miami-Dade county and who according to CCP screening are rated as high risk for re-offending. Youth are 12-17 years old with a first or second misdemeanor charge (excluding any gang, violence, or sex crimes charge). Nearly all (97%) of these youth are ethnic minorities (Hispanic and African American). They are at risk for school failure, substance use, and chronic delinquency due to drug availability in their communities, poor family functioning, peer drug use/delinquency, and school failure / disengagement.

120 youth who enter the Civil Citation Program and are eligible for the study will be assigned to one of the two interventions: CCP+SAU or the experimental intervention, CCP+MDFT.

The study asks a classical services research question(Compton et al, 2005) - does the addition of a family therapy intervention, multidimensional family therapy, into an existing diversion program significantly enhance the program outcomes in key outcome domains: recidivism, substance use, delinquency, school and family functioning.

Being tested
CCP+MDFT, CCP+SAU
Keywords
Adolescents, Family-Based treatment, Multidimensional Family Therapy
Medical subject headings
Substance-Related Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CCP+MDFTBehavioural

    Multidimensional Family Therapy (MDFT; Liddle, 2002) is one of a new generation of multi-systems oriented family-based intervention for adolescent substance abuse and delinquency. It has demonstrated considerable success with juvenile justice youth at various stages of their involvement in the justice system. The model has demonstrated efficacy in reducing substance use and delinquency, increasing the prosocial behaviors (e.g., family functioning, school outcomes) of substance abusing and court involved adolescents.

  • CCP+SAUBehavioural

    Services As Usual community partners will provide individualized mental health counseling and psychiatric services, psychoeducational groups and substance abuse counseling.

Study groups in NCT02147743
Study groupRoleWhat they receive
CCP+MDFTExperimentalMultidimensional Family Therapy (MDFT) is a multisystemic, flexible intervention system (Liddle, 2002). It is a strengths-based approach promoting protective factors and reducing risk factors for delinquency, substance use, and school problems. MDFT organizes interventions in key areas of the teen's life: self of the adolescent (includes HIV-STD risk behaviors), parenting, family environment, and school/vocational functioning.
Receives: Behavioral: CCP+MDFT
CCP+SAUOtherServices as Usual (SAU) are determined on a case-by-case basis by the CCP Case Manager. SAU includes a variety of services offered by a number of community partners.
Receives: Behavioral: CCP+SAU

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Delinquency

    Youth in CCP+MDFT will show less delinquency from intake to 9 months than youth in CCP+SAU.

    National Youth Survey Self-Report Delinquency Scale (SRD)will be used to assess delinquency.

    Measured: Intake through 9-month follow-up

  2. Recidivism

    Juvenile justice arrest records recoding total arrests, total misdemeanor arrests, and total felony arrests for youth 6 months prior to baseline through 24 months after baseline.

    Measured: 6 months prior to arrest that got youth in the CCP through 24 months after the baseline assessment

Secondary outcomes (1)
  1. Substance Use

    Youth in CCP+MDFT will report less substance use from intake to 9 months than CCP+SAU. The Timeline Follow-Back Method, Personal Experiences Inventory and Urinalyses will be used to measure substance use.

    Measured: Intake through the 9-month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 May 2014 (estimated)
  2. Study startMay 2009
  3. Primary completionJan 2013
  4. Study completionJan 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02147743
Sponsor's protocol ID
20080174
Acronym
CCP
Status last verified
May 2014
First submitted
21 May 2014
Last updated
28 May 2014
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing CCP+MDFT and CCP+SAU in people with Substance Use and Delinquency, run by University of Miami at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 May 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Delinquency (time frame: Intake through 9-month follow-up). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 May 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in